Jennifer T. Fox

发表

Scheme 1, Synthetic route to ML367 is a 2 step process

Ruili Huang, Menghang Xia, David J. Maloney, 2013 .

Mechanism of the Internal Ribosome Entry Site-mediated Translation of Serine Hydroxymethyltransferase 1*

Jennifer T. Fox, P. Stover, Jennifer T Fox, 2009, The Journal of Biological Chemistry.

High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell death

Ruili Huang, Christopher P Austin, Raymond R Tice, 2012, Proceedings of the National Academy of Sciences.

Characterization of stage‐specific tumor progression in TMPRSS2‐ERG (fusion)‐driven and non‐fusion‐driven prostate cancer in GEM models

Jennifer T. Fox, R. Shoemaker, R. Agarwal, 2022, Molecular carcinogenesis.

Cell-based high-throughput screens for the discovery of chemotherapeutic agents

Jennifer T. Fox, K. Myung, Jennifer T Fox, 2012, Oncotarget.

Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA Expression

Jennifer T. Fox, Altaf Mohammed, R. Lubet, 2021, Bladder Cancer.

Effects of High-Fructose Diet vs. Teklad Diet in the MNU-Induced Rat Mammary Cancer Model: Altered Tumorigenesis, Metabolomics and Tumor RNA Expression

Jennifer T. Fox, W. Nelson, R. Lubet, 2021, Journal of obesity and chronic diseases.

Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models*

Jennifer T. Fox, Mindy I. Davis, L. DeLucas, 2016, The Journal of Biological Chemistry.

A Novel Chemotherapeutic Agent to Treat Tumors with DNA Mismatch Repair Deficiencies.

Jennifer T. Fox, Ruili Huang, M. Xia, 2016, Cancer research.

Effects of High-Fructose Diet vs. Teklad Diet in the MNU-Induced Rat Mammary Cancer Model: Altered Tumorigenesis, Metabolomics and Tumor RNA Expression

Jennifer T. Fox, W. Nelson, R. Lubet, 2021, Journal of obesity and chronic diseases.